BLSM Stock Price, Chart, Stats & News

BlossomHill Therapeutics, Inc.
Save
BlossomHill Therapeutics, Inc. (BLSM) does not currently pay a dividend.
470.53M
Market cap
–
Current P/E
–
Forward P/E
BLSM chart
1M
3M
1Y
5Y
Loading chart...
About
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.
Similar securities
Based on sector and market capitalization
Report issue





